期刊文献+

慢性肾脏病患者血清HE4与CA125的变化及临床意义 被引量:5

The changes and clinical significance of HE4 and CA125 in patients with chronic kidney disease
下载PDF
导出
摘要 目的探讨慢性肾脏病(CKD)患者不同时期血清人附睾蛋白4(HE4)和糖类抗原125(CA125)水平的变化及临床意义。方法选取各期CKD(CKD 1-5)患者共66例,健康体检者(健康对照组)40例。分别采用电化学发光法检测各组血清HE4、CA125水平,同时用肌氨酸氧化酶法测定患者血清肌酐(SCr),散射比浊法检测患者尿微量清蛋白(mALB)、α1-微球蛋白(α1-MG)水平,用MDRD简化方程计算肾小球滤过率估算值(eGFR)。结果血清HE4在CKD各阶段均高于健康对照组,差异有统计学意义(P〈0.05),且各阶段患者血清间HE4差异均有统计学意义(P〈0.05);与患者eGFR呈负相关(r=-0.532,P〈0.05),与患者尿α1-MG呈正相关(r=0.279,P=0.048)。血清CA125水平在CKD1阶段没有明显增高(P=0.06),但在CKD2-5阶段明显增高,差异有统计学意义(P〈0.05)。但各阶段患者血清CA125间差异均无统计学意义(P〉0.05);患者血清CA125与eGFR、尿mALB、α1-MG均无明显相关性(P〉0.05)。结论血清HE4水平变化与CKD的发生发展有关,对判断CKD的分期有重要的意义,可能作为判断CKD严重程度的重要指标。 Objective To investigate the changes and clinical significance of serum concentrations of epididymis protein 4(HE4)and carbohydrate antigen 125(CA125)in different stages of chronic kidney disease(CKD).Methods A total of 66 CKD patients at different stages(CKD 1-5)and 40 healthy volunteers(health control group)with normal renal and ovarian function were enrolled.The determinations of serum HE4,CA125 were analysed by electrochemiluminescence,and serum creatinine(SCr)was analysed by sarcosine oxidase method,urinary microalbumin(mALB)andα1microglobulin(α1-MG)were analysed by scattering immunoturbidimetric assay.Estimated glomerular filtration rate(eGFR)was calculated by the simplified MDRD formula.Results Significantly increased of HE4 concentrations were found in individuals in different stages of CKD compared with health control group(P〈0.05).There were significant increase in serum HE4 among different stages compared with each other(P〈0.05).Significantly negatively correlation was found between serum HE4 and eGFR(r=-0.532,P〈0.05),while significantly positively correlation was found between serum HE4 and urinaryα1-MG(r=0.279,P=0.048).There was no significant increase in serum CA125 in the stage of CKD1(P=0.06),while significantly increased CA125 concentrations were found in individuals in different stages of CKD2-5compared with clinical controls(P〈0.05).However,there was no significant increase in serum CA 125 among different stages compared with each other(P〈0.05).And there was also no significant correlation between serum CA125 and eGFR,α1-MG and mALB(P〈0.05).Conclusion The change of serum HE4 level is related to the occurrence and development of CKD,further morer,it is closely associated with the severity of CKD,may be it′s an important index for judging the stages of CKD.
出处 《检验医学与临床》 CAS 2016年第11期1504-1506,共3页 Laboratory Medicine and Clinic
关键词 慢性肾脏病 人附睾蛋白4 糖类抗原125 肌酐 Α1-微球蛋白 chronic kidney disease human epididymis protein 4 carbohydrate antigen 125 creatinine α1 microglobulin
  • 相关文献

参考文献10

  • 1张路霞,王芳,王莉,王文科,刘必成,刘健,陈孟华,何强,廖蕴华,余学清,陈楠,张建鄂,胡昭,刘伏友,洪大情,马立杰,刘宏,周晓玲,陈江华,潘玲,陈崴,王伟铭,李晓玫,王海燕.中国慢性肾脏病患病率的横断面调查[J].中华内科杂志,2012,51(7):570-570. 被引量:74
  • 2Anton C,Carvalho FM, Oliveira EI, et al. A comparison of CA125, HE4, risk ovarian malignancy algorithm (RO-MA) ,and risk malignancy index (RMI) for the classifica- tion of ovarian masses[J]. Clinics,2012,67(5) :437-441.
  • 3Partheen K,Kristjansdottir B,Sundfeldt K. Evaluation of ovarian cancer biomarkers HE4 and CA-125 in women presenting with a suspicious cystic ovarian mass[J]. J Gy- necol Oncol,2011,22(4) :244-252.
  • 4Sandri MT, Bottari F, Franchi D, et al. Comparison of HE4, CA125 and ROMA algorithm in women with a pelvic mass: correlation with pathological outcome [J]. Gynecol Oncol, 2013,128(2): 233-238.
  • 5Galgano MT, Hampton GM,Frierson HF. Comprehensive analysis of HE4 expression in normal and malignant hu- man tissues[J]. Mod Pathol,2006,19(6) :847-853.
  • 6Nagy B,Krasznai ZT, Balta H, et al. Elevated human epi- didymis protein 4 concentrations in chronic kidney disease [J].Ann Clin Biochem,2012,49(Pt 4) :377-380.
  • 7徐光标,陈德君,蔡红芳.肾病综合征患者血清CA125水平变化[J].中国中西医结合肾病杂志,2010,11(6):519-520. 被引量:5
  • 8National Kidney Foundation. K/DOQI clinical practice guide- lines for chronic kidney disease: evaluation, classification, and stratification[J]. Am J Kidney Dis, 2002,39 (2 Suppl 1) : S1- 266.
  • 9Lebleu VS, Teng Y, Or connell JT, et al. Identification of human epididymis protein-4 as a fibroblast-derived media- tor of fibrosis[J]. Nat Med,2013,19(2) :227-231.
  • 10徐瑾,胡芳.原发性肾病和糖尿病肾病患者蛋白尿与肿瘤标志物的相关性[J].检验医学与临床,2015,12(15):2276-2278. 被引量:5

二级参考文献17

  • 1张悦,叶志斌,吉俊.肿瘤标记物在原发性肾脏疾病患者中的血清学浓度改变[J].中国临床医学,2005,12(1):135-137. 被引量:10
  • 2徐夏莲,叶志斌.慢性肾脏疾病患者中血清肿瘤标志物水平的变化[J].复旦学报(医学版),2007,34(1):150-152. 被引量:10
  • 3Akashi Y,Inoh M,Gamo N,et al.Dermatomyositis associated with membranous nephropathy in a 43-year-old female.Am J Nephrol,2002,22(4):385.
  • 4Sevinc A,Buyukber S,Sari R,et al.Elevated serum CA125 levels in patients with nephritic syndrome-induced ascites.Anticancer Res,2000,20(2B):1201.
  • 5Epiney M,Bertossa C,Weil A,et al.CA-125 production by the peritoneum:in-vitro and in-vivo studies.Human Reproduction,2000,15(6):1261-1265.
  • 6Xiao WB,Liu YL.Elevation of serum and ascites cancer antigen 125 levels in patients with live rcirrhosis.J Gastroenterol Hepatol,2003,18(11):1315.
  • 7Camci C,Buyukberber S,Tarakcioglu M,et al.The effect of Continuous ambulatory peritoneal dialysis on serum CA-125 levels.Eur J Gynaecol Oncol,2002,23(5):472.
  • 8Kaneta Y,Nishino R,Asaoka K,et al.Ovarian hemangioma presenting as pseudo-Meigs csyndrome with elevated CA125.J Obstet Gynaecology Res,2003,29(3):132-135.
  • 9Sevinc A, Adli M, Kalender ME, et al. Benign causes ofincreased serum CA125 concentration[J]. Lancet Oncol,2007,8(12):1054-1055.
  • 10Joven J, Clivilie X, Camps J, et al. Plasma protein abnor-malities in nephrotic syndrome: effect on plasma colloidosmotic pressure and viscosity [J]. Clin Chem, 1997,43(7):1223-1231.

共引文献81

同被引文献48

引证文献5

二级引证文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部